{"id":458114,"date":"2019-12-19T14:12:01","date_gmt":"2019-12-19T14:12:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=458114"},"modified":"2019-12-19T14:12:01","modified_gmt":"2019-12-19T14:12:01","slug":"gastric-cancer-drugs-market-to-grow-at-a-cagr-of-111-during-20182022","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/gastric-cancer-drugs-market-to-grow-at-a-cagr-of-111-during-20182022_458114.html","title":{"rendered":"Gastric Cancer Drugs Market To Grow At A CAGR Of 11.1% During 2018-2022"},"content":{"rendered":"
\"Gastric<\/a><\/p>\n
\n
Gastric Cancer Drugs Global Market Report 2019<\/div>\n<\/div>\n<\/div>\n
Eli Lilly And Company Is One Of The Largest Companies In The Gastric Cancer Drugs Market, According To TBRC\u2019s Report
\n(Companies: Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche)\n<\/div>\n

Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses.<\/strong><\/em><\/p>\n

https:\/\/www.thebusinessresearchcompany.com\/discounted-reports.aspx<\/a><\/p>\n

The gastric cancer drugs market consists of sales of drugs for gastric cancer. Gastric cancer, also known as stomach cancer, is the formation of abnormal cells on the lining of stomach resulting in stomach pain and indigestion. Browse Complete Report @ https:\/\/www.thebusinessresearchcompany.com\/report\/gastric-cancer-drugs-global-market-report<\/a><\/p>\n

The global gastric cancer drugs market was valued at about $1.4 billion in 2018 and is expected to grow to $2.13 billion at a CAGR of 11.1% through 2022. Asia Pacific was the largest region in the gastric cancer drugs market in 2018 and is forecasted to register the highest CAGR during 2018-2023. Increasing number of obesity cases and smoking population increased number of people suffering from gastric cancer. Consuming tobacco and following diet unhealthy diet increases the risk of stomach cancer. According to American Institute For Cancer Research ,1 million new cases of stomach cancer have been reported in 2018. Similarly, according to the estimates of American Cancer Society in 2019, about 27,510 cases of stomach cancer will be diagnosed and 11,140 people will die from stomach cancer. Increase in number of cases in gastric cancer will drive the market for gastric cancer drugs.<\/p>\n

Major players in the market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche.<\/p>\n

Request A Sample Of The Global Gastric Cancer Drugs Market Report At: <\/strong>https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=2603&type=smp<\/a><\/p>\n

 <\/p>\n

Points From Table of Contents: <\/strong><\/p>\n

2. Gastric Cancer Drugs Market Characteristics<\/p>\n

3. Gastric Cancer Drugs Market Size And Growth<\/p>\n

3.1. Global Gastric Cancer Drugs Historic Market, 2014 – 2018, $ Billion<\/p>\n

3.1.1. Drivers Of The Market<\/p>\n

3.1.2. Restraints On The Market<\/p>\n

3.2. Global Gastric Cancer Drugs Forecast Market, 2018 – 2022F, 2025F, 2030F, $ Billion<\/p>\n

3.2.1. Drivers Of The Market<\/p>\n

3.2.2. Restraints On the Market<\/p>\n

4. Gastric Cancer Drugs Market Segmentation<\/p>\n

4.1. Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

Doxorubicin Hydrochloride<\/p>\n

Sunitinib<\/p>\n

Docetaxel<\/p>\n

Mitomycin<\/p>\n

Fluorouracil<\/p>\n

Imatinib<\/p>\n

Trastuzumab<\/p>\n

4.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

Hospitals<\/p>\n

Clinics<\/p>\n

Others<\/p>\n

4.3. Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

Oral<\/p>\n

Parenteral<\/p>\n

5. Gastric Cancer Drugs Market Regional And Country Analysis<\/p>\n

5.1. Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

5.2. Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

6. Asia-Pacific Gastric Cancer Drugs Market  <\/p>\n

6.1. Asia-Pacific Gastric Cancer Drugs Market Overview  <\/p>\n

6.2. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

6.3. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion<\/p>\n

7. China Gastric Cancer Drugs Market  <\/p>\n

Purchase a Copy Of Complete Report @<\/strong> https:\/\/www.thebusinessresearchcompany.com\/purchaseoptions.aspx?id=2603<\/a>  <\/strong><\/p>\n

About The Business Research Company<\/strong><\/p>\n

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 20 countries globally.<\/p>\n

Contact Information<\/p>\n

The Business Research Company<\/p>\n

Europe: +44 207 1930 708<\/p>\n

Asia: +91 8897263534<\/p>\n

Americas: +1 315 623 0293<\/p>\n

Email: info@tbrc.info<\/p>\n

Follow us on LinkedIn: https:\/\/in.linkedin.com\/company\/the-business-research-company<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Business Research Company<\/a>
Contact Person:<\/strong> Nitin
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 08897263534
Address:<\/strong>1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City:<\/strong> Hyderabad 500033
State:<\/strong> Telengana
Country:<\/strong> India
Website:<\/strong> https:\/\/www.thebusinessresearchcompany.com\/report\/gastric-cancer-drugs-global-market-report<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Gastric Cancer Drugs Global Market Report 2019 Eli Lilly And Company Is One Of The Largest Companies In The Gastric Cancer Drugs Market, According To TBRC\u2019s Report (Companies: Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche) … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,406,420,411,415],"tags":[],"class_list":["post-458114","post","type-post","status-publish","format-standard","hentry","category-Business","category-Pharmaceuticals-Biotech","category-Science","category-Technology","category-Transportation-Logistics"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/458114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=458114"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/458114\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=458114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=458114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=458114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}